No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs12971445 |
chr19:41484602-41484603 |
Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
2 |
rs574489240 |
chr19:41484606-41484607 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs541907407 |
chr19:41484644-41484645 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs563388616 |
chr19:41484645-41484646 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs576552517 |
chr19:41484710-41484711 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs145273754 |
chr19:41484735-41484736 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs183061689 |
chr19:41484797-41484798 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs147651450 |
chr19:41484798-41484799 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs548115187 |
chr19:41484824-41484825 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs367686951 |
chr19:41484857-41484858 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs554751904 |
chr19:41484886-41484887 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs79152072 |
chr19:41484890-41484891 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs548239167 |
chr19:41484909-41484910 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs188471028 |
chr19:41484922-41484923 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs537589622 |
chr19:41484927-41484928 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs552081081 |
chr19:41484930-41484931 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs77159062 |
chr19:41484943-41484944 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs75889152 |
chr19:41485007-41485008 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs543649116 |
chr19:41485050-41485051 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs553314378 |
chr19:41485144-41485145 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs1808002 |
chr19:41485194-41485195 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
22 |
rs535464775 |
chr19:41485211-41485212 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs397970243 |
chr19:41485243-41485244 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs372605508 |
chr19:41485244-41485245 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs557024332 |
chr19:41485282-41485283 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs559166276 |
chr19:41485302-41485303 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs192894682 |
chr19:41485310-41485311 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs151166009 |
chr19:41485328-41485329 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs545908382 |
chr19:41485346-41485347 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs56881024 |
chr19:41485380-41485381 |
Enhancers Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
31 |
rs371708821 |
chr19:41485381-41485382 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs11443247 |
chr19:41485405-41485406 |
Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs71358953 |
chr19:41485408-41485409 |
Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs374975103 |
chr19:41485439-41485440 |
Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs367902385 |
chr19:41485450-41485451 |
Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs554458842 |
chr19:41485451-41485452 |
Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs559632408 |
chr19:41485462-41485463 |
Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs530006139 |
chr19:41485476-41485477 |
Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs185044055 |
chr19:41485496-41485497 |
Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs563385724 |
chr19:41485521-41485522 |
Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs189508457 |
chr19:41485529-41485530 |
Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs552646282 |
chr19:41485621-41485622 |
Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs570514388 |
chr19:41485652-41485653 |
Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs76421816 |
chr19:41485688-41485689 |
Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs183528325 |
chr19:41485696-41485697 |
Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs568340012 |
chr19:41485697-41485698 |
Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs535781998 |
chr19:41485698-41485699 |
Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs556987149 |
chr19:41485740-41485741 |
Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs8106966 |
chr19:41485821-41485822 |
Enhancers Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
50 |
rs189390480 |
chr19:41485826-41485827 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|